BREAST CANCER METASTATIC
Clinical trials for BREAST CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER METASTATIC trials appear
Sign up with your email to follow new studies for BREAST CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat advanced breast cancer
Disease control Recruiting nowThis study is testing a new drug called evorpacept, given alongside standard cancer treatments, for people with advanced breast cancer that has spread and stopped responding to prior therapy. It aims to see if this combination can better control the cancer and is safe for patient…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested for Tough-to-Treat breast cancer
Disease control Recruiting nowThis early-stage trial is testing whether adding an experimental drug called avasopasem to standard breast cancer therapy is safe and might help when the initial treatment stops working. The study will enroll about 35 women with metastatic, hormone receptor-positive breast cancer…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Tracking a new hope for advanced breast cancer patients
Disease control Recruiting nowThis study aims to see how well a drug called sacituzumab govitecan works for patients with advanced HER2-negative breast cancer in real-world medical settings across China. It will follow about 200 patients who have already received this treatment to measure how long the cancer …
Matched conditions: BREAST CANCER METASTATIC
Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New combo attack on spreading breast cancer
Disease control Recruiting nowThis early-stage study aims to find the safest and most effective dose of the drug abemaciclib when given at the same time as targeted radiation therapy. It is for people with advanced, hormone-sensitive breast cancer that has spread to the bones. The goal is to see if this combi…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for tough cancers: First-of-its-Kind antibody trial targets common growth signal
Disease control Recruiting nowThis study is testing a new antibody drug called OM-RCA-01 in people with advanced cancers that have spread and have a specific protein (FGFR1). The main goals are to find a safe dose and see if the drug can slow down tumor growth. About 58 people with certain types of metastatic…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Kidney Cancer Research Bureau • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Radical stem cell combo aims to outsmart tough cancers
Disease control Recruiting nowThis early-stage trial is testing a new treatment for people with metastatic pancreatic or breast cancer. The goal is to see if a combination of high-dose chemotherapy drugs, vitamins, and the patient's own stem cells is safe and can overcome the cancer's resistance to treatment.…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1 • Sponsor: General Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for End-Stage breast cancer patients in major trial
Disease control Recruiting nowThis study is testing whether a new immunotherapy combination can help people with advanced metastatic breast cancer live longer when standard treatments have stopped working. The trial will compare the experimental treatment against whatever therapy a doctor would normally choos…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE3 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New cancer drug enters first human tests for multiple tumor types
Disease control Recruiting nowThis early-stage study is testing a new drug called Sapu003 in people with advanced cancers that have spread or cannot be removed by surgery. The main goal is to find the safest and most effective dose, and to see how the body processes the drug. The study includes 27 adults with…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1 • Sponsor: SAPU NANO (US) LLC • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New pill targets Tough-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study is testing a new oral medication called INX-315 in people with advanced cancers that have spread or stopped responding to standard treatments. It aims to find a safe dose and see if the drug can help control cancers like certain types of breast and ovarian …
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Incyclix Bio • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New hope drug enters human testing for ten types of advanced cancer
Disease control Recruiting nowThis is the first human study of an experimental drug called SLV-154 for people with advanced solid tumors that have spread. The main goal is to find the highest safe dose and understand how the body processes the drug. About 70 adults with one of ten specific advanced cancers wh…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New hope for Tough-to-Treat breast cancer: drug trial targets 'HER2-Zero' tumors
Disease control Recruiting nowThis study is testing a drug called trastuzumab deruxtecan (T-DXd) in adults whose advanced breast cancer has spread and has tested completely negative for a protein called HER2. The goal is to see if this drug, which combines a targeted antibody with a chemotherapy agent, can sh…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Scientists test 'Switchable' cell therapy to fight advanced breast cancer
Disease control Recruiting nowThis is an early study to test the safety of a new two-part treatment for people with advanced breast cancer that has spread or cannot be removed by surgery. The treatment involves giving patients their own modified immune cells (CLBR001), followed by a biologic drug (ABBV-461) t…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
New scan could sharpen breast cancer detection
Diagnosis Recruiting nowThis study is testing two new imaging agents for PET/CT scans to see if they can better detect and characterize breast cancer tumors. The goal is to see if these new scans can more accurately show where cancer is located and how much of certain proteins the tumors have. This coul…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Apr 01, 2026 21:41 UTC
-
Blood test could offer less invasive way to guide breast cancer treatment
Diagnosis Recruiting nowThis study aims to improve the diagnosis of metastatic breast cancer by comparing different methods of testing for a specific gene mutation called PIK3CA. Researchers will test 100 patients using both a standard tissue biopsy and a less invasive blood test (liquid biopsy) to see …
Matched conditions: BREAST CANCER METASTATIC
Sponsor: European Institute of Oncology • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
New glowing dye could give surgeons instant cancer spread map
Diagnosis Recruiting nowThis study is testing a new imaging technique to help surgeons see if breast cancer has spread to nearby lymph nodes during surgery. Doctors apply a special fluorescent dye to the removed lymph node tissue and use a special camera to see if cancer cells are present. The goal is t…
Matched conditions: BREAST CANCER METASTATIC
Sponsor: Yunnan Cancer Hospital • Aim: Diagnosis
Last updated Mar 30, 2026 14:27 UTC
-
Researchers ask: are cancer survivors ready to change their diet?
Knowledge-focused Recruiting nowThis online study aims to understand the perspectives of women who have completed treatment for early-stage breast cancer. Researchers want to know if these women are willing and able to make healthier food choices, particularly by reducing processed foods. Participants will comp…
Matched conditions: BREAST CANCER METASTATIC
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:41 UTC